Sign in

CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465087339
Phone
346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
  1. EFFECT Other Notice of Effectiveness
  2. 424B3 Offering Prospectus
  3. S-1 Offering Registration Statement
  4. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  5. 8-K Event Shareholder vote results
  6. 4 Grant or award Director acquired 2,000 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 33,455 shares (grant or award)
  8. 4 Grant or award Chief Business Officer acquired 3,900 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 9,682 shares (grant or award)
  10. 4 Grant or award Chief Scientific Officer acquired 4,216 shares (grant or award)
  11. 4 Grant or award Director acquired 3,000 shares (grant or award)
  12. 4 Grant or award Director acquired 2,000 shares (grant or award)
  13. 4 Grant or award Director acquired 2,000 shares (grant or award)
  14. 4 Grant or award Director acquired 3,000 shares (grant or award)
  15. 4 Grant or award Director acquired 2,000 shares (grant or award)
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 10-Q Report Quarterly Report
  18. DEF 14A Proxy Proxy Statement
  19. DEFA14A Proxy Proxy Materials
  20. 3 Insider Initial Statement of Ownership

Page 1 of 38 · 743 filings